Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gussoni

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Recenti Progressi in Medicina|July 1, 1991
[Zidovudine in the treatment of HIV-related thrombocytopenia. A study of 11 cases]L Steidl, G Gussoni, M Montanari, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study GroupM Giusti, G Gussoni, C M Cuttica, et al.
FEBS Letters|November 18, 1996
A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell linesM G Cattaneo, D Amoroso, G Gussoni, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 21, 2006
Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolismA C Pessina, L Ciccariello, F Perrone, et al.
Journal of Biological Regulators and Homeostatic Agents|September 23, 2016
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trialA Mazza, A F Cicero, E Ramazzina, et al.
European Journal of Clinical Investigation|April 1, 1997
Clinical results of long-term slow-release lanreotide treatment of acromegalyM Giusti, E Ciccarelli, D Dallabonzana, et al.
European Journal of Endocrinology|October 20, 1999
Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitroT Florio, S Thellung, S Arena, et al.
Diabetes Research and Clinical Practice|June 1, 2016
Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: Findings from the FADOI-DIAMOND studyV Borzì, S Frasson, G Gussoni, et al.
Aging Clinical and Experimental Research|December 18, 2013
E-learning to improve the drug prescribing in the hospitalized elderly patients: the ELICADHE feasibility pilot studyC Franchi, D Mari, M Tettamanti, et al.
Infection|October 23, 2020
Clinical characteristics, management and outcome of patients with invasive candidiasis hospitalized in Internal Medicine Units: findings from a registry by the Italian Scientific Society FADOIF Pieralli, F Dentali, M Giusti, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Recenti Progressi in Medicina|July 1, 1991
[Zidovudine in the treatment of HIV-related thrombocytopenia. A study of 11 cases]L Steidl, G Gussoni, M Montanari, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study GroupM Giusti, G Gussoni, C M Cuttica, et al.
FEBS Letters|November 18, 1996
A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell linesM G Cattaneo, D Amoroso, G Gussoni, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 21, 2006
Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolismA C Pessina, L Ciccariello, F Perrone, et al.
Journal of Biological Regulators and Homeostatic Agents|September 23, 2016
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trialA Mazza, A F Cicero, E Ramazzina, et al.
European Journal of Clinical Investigation|April 1, 1997
Clinical results of long-term slow-release lanreotide treatment of acromegalyM Giusti, E Ciccarelli, D Dallabonzana, et al.
European Journal of Endocrinology|October 20, 1999
Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitroT Florio, S Thellung, S Arena, et al.
Diabetes Research and Clinical Practice|June 1, 2016
Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: Findings from the FADOI-DIAMOND studyV Borzì, S Frasson, G Gussoni, et al.
Aging Clinical and Experimental Research|December 18, 2013
E-learning to improve the drug prescribing in the hospitalized elderly patients: the ELICADHE feasibility pilot studyC Franchi, D Mari, M Tettamanti, et al.
Infection|October 23, 2020
Clinical characteristics, management and outcome of patients with invasive candidiasis hospitalized in Internal Medicine Units: findings from a registry by the Italian Scientific Society FADOIF Pieralli, F Dentali, M Giusti, et al.
Pageof 2